title: [Management of the esophageal candidiasis by the primary care physician].
abstract: Esophageal candidiasis is one of the most common opportunistic infections in patients infected by human immunodeficiency virus (HIV). This pathology is also found in patients without overt immunodeficiency. Other risk factors are known to be associated with this disease like inhaled or systemic corticosteroid treatment or proton-pump inhibitors and H2 receptor antagonists. In the absence of identified risk factors, a primary immune deficiency should be sought. Prevention of esophageal candidiasis is based primarily on the identification of risk factors, and a better control of them. This article presents a review of the physiopathology, clinical presentation and management of esophageal candidiasis by primary care physicians. We will also discuss ways of preventing esophageal candidiasis when necessary.
authors.forename: Garance
authors.initials: G
authors.lastname: Behrens
authors.forename: Astrid
authors.initials: A
authors.lastname: Bocherens
authors.forename: Nicolas
authors.initials: N
authors.lastname: Senn
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D002177:Candidiasis / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy*; D004935:Esophageal Diseases / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy*; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects; D006635:Histamine H2 Antagonists / Q000009:adverse effects; D006801:Humans; D010819:Physician's Role; D058007:Physicians, Primary Care; D011320:Primary Health Care / Q000379:methods*; D054328:Proton Pump Inhibitors / Q000009:adverse effects; D012307:Risk Factors
chemical_list: D005938:Glucocorticoids; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors